• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

What to make of Freshworks’ first IPO price range

September 13, 2021 by David Barret Leave a Comment

Two major private tech companies announced IPO price ranges this morning, with Toast targeting a market value of nearly $18 billion at the top end of its range and Freshworks looking to price its equity between $28 and $32 per share. TechCrunch calculates that the company would be worth around $8.9 billion at $32 per share, not employing a fully diluted share count.

Inclusive of shares represented by fully vested options and the like, Freshworks’ valuation could reach $9.6 billion, Renaissance Capital reports.

Unlike Toast, with a revenue mix including four distinct products, Freshworks is a more straightforward software company. That means we can do much more interesting work to understand its valuation. So, this morning, let’s unpack how Freshworks is considering valuing itself in its IPO at its present range, look at some market comps, and come to a conclusion regarding whether or not we expect the unicorn to raise its valuation before it floats.

Lies, damned lies and revenue multiples

As a refresher, in the first half of 2021 (Q1 and Q2), Freshworks posted revenues of $168.9 million. That annualizes to $337.9 million, thanks to numerical rounding.

At a valuation of $9.6 billion — recall that simple IPO valuations for the company and lower share-price points from its IPO range generate lower valuations and therefore more conservative multiples than what we’ll be discussing here — Freshworks would be worth 28.4x its current revenue run rate, set during H1 2021.

Source Link What to make of Freshworks’ first IPO price range

David Barret
David Barret

Related posts:

  1. Chevron braces for activist challenge; meets Engine No.1 representatives- WSJ
  2. Acquired by Mercedes-Benz, YASA’s revolutionary electric motor is set for big things
  3. European stocks mark worst fall in 2 weeks on U.S. job jitters
  4. Tennis – U.S. Open order of play on Saturday

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • What’s The Biggest Rock In The World?
  • There Is A Very Simple Test To See If You Have Aphantasia
  • Bringing Extinct Animals To Life: Is Artificial Intelligence Helping Or Harming Palaeoart?
  • This Brilliant Map Has 3D Models Of Nearly Every Single Building In The World – All 2.75 Billion Of Them
  • These Hognose Snakes Have The Most Dramatic Defense Technique You’ve Ever Seen
  • Titan, Saturn’s Biggest Moon, Might Not Have A Secret Ocean After All
  • The World’s Oldest Individual Animal Was Born In 1499 CE. In 2006, Humans Accidentally Killed It.
  • What Is Glaze Ice? The Strange (And Deadly) Frozen Phenomenon That Locks Plants Inside Icicles
  • Has Anyone Ever Actually Been Swallowed By A Whale?
  • First-Known Instance Of Bees Laying Eggs In Fossilized Tooth Sockets Discovered In 20,000-Year-Old Bones
  • Polar Bear Mom Adopts Cub – Only The 13th Known Case Of Adoption In 45 Years Of Study At Hudson Bay
  • The Longest-Running Evolution Experiment Has Been Going For 80,000 Generations
  • From Shrink Rays And Simulated Universes To Medical Mishaps And More: The Stories That Made The Vault In 2025
  • Fastest Cretaceous Theropod Yet Discovered In 120-Million-Year-Old Dinosaur Trackway
  • What’s The Moon Made Of?
  • First Hubble View Of The Crab Nebula In 24 Years Is A Thing Of Beauty… With Mysterious “Knots”
  • “Orbital House Of Cards”: One Solar Storm And 2.8 Days Could End In Disaster For Earth And Its Satellites
  • Astronomical Winter Vs. Meteorological Winter: What’s The Difference?
  • Do Any Animal Species Actively Hunt Humans As Prey?
  • “What The Heck Is This?”: JWST Reveals Bizarre Exoplanet With Inexplicable Composition
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version